AcelRx Pharmaceuticals Inc (ACRX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Vincent J. Angotti
Employees:
61
351 GALVESTON DRIVE, REDWOOD CITY, CA 94063
650-216-3500

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. Its product candidates is comprised of DSUVIA, and ZALVISO, which both contains sufentanil as a therapeutic ingredient. The company was founded by Thomas A. Schreck and Pamela P. Palmer on July 13, 2005 and is headquartered in Redwood City, CA.

Data derived from most recent annual or quarterly report
Market Cap 108.334 Million Shares Outstanding119.18 Million Avg 30-day Volume 709.047 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 2.94 / 0.75 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from ACRX instead.

View recent insider trading info

Funds Holding ACRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ACRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HOFFMAN STEPHEN J

  • Director
41,250 2021-06-17 1

EDWARDS MARK G

  • Director
281,250 2021-06-17 1

WAN MARK A

  • Director
41,250 2021-06-17 1

ADAMS ADRIAN

  • Director
216,250 2021-06-17 1

ROSEN HOWARD B

  • Director
98,750 2021-06-17 1

AFABLE RICHARD

  • Director
42,250 2021-06-17 1

BOZILENKO MARINA

  • Director
45,000 2021-06-17 3

DASU BADRI N CHIEF ENGINEERING OFFICER

  • Officer
354,757 2021-03-03 3

PALMER PAMELA P CHIEF MEDICAL OFFICER

  • Officer
  • Director
872,871 2021-03-03 3

ASADORIAN RAFFI CHIEF FINANCIAL OFFICER

  • Officer
466,847 2021-03-03 3

ANGOTTI VINCENT J. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,636,980 2021-03-03 3

HAMEL LAWRENCE G CHIEF DEVELOPMENT OFFICER

  • Officer
157,564 2020-02-11 0

HOFFMAN C STEVEN

  • Director
0 2018-06-14 0

WAN MARK A

JAEGER WILFRED E

THREE ARCH PARTNERS IV LP

THREE ARCH PARTNERS III LP

THREE ARCH ASSOCIATES IV LP

THREE ARCH ASSOCIATES III LP

  • Director
  • 10% Owner
0 2018-05-21 0

SAIA JOHN G. GENERAL COUNSEL AND SECRETARY

  • Officer
0 2018-04-16 0

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • 10% Owner
No longer subject to file 2017-06-19 0

MORRIS TIMOTHY E CHIEF FINANCIAL OFFICER

  • Officer
0 2017-02-07 0

MITCHELL JANE WRIGHT CHIEF LEGAL OFFICER

  • Officer
0 2017-02-07 0

YATRA ONLINE, INC. CHIEF FINANCIAL OFFICER

  • Officer
0 2014-03-25 0

SKYLINE VENTURE PARTNERS QUALIFIED PURCHASER FUND IV L P

SKYLINE VENTURE MANAGEMENT IV, LLC

FREUND JOHN GORDON

KANEKO YASUNORI

  • 10% Owner
  • FORMER 10% HOLDER
No longer subject to file 2014-03-07 0

KING RICHARD

  • Director
134,567 2014-03-02 0

WELCH JAMES H CHIEF FINANCIAL OFFICER

  • Officer
0 2014-02-04 0

CHUNG DAVID CHIEF COMMERCIAL OFFICER

  • Officer
0 2014-02-04 0

NOHRA GUY P

  • Director
2,507,974 2013-09-19 0

SCHRECK THOMAS A

  • Director
0 2012-07-24 0

WAN MARK A

JAEGER WILFRED E

THREE ARCH PARTNERS III LP

THREE ARCH ASSOCIATES III LP

THREE ARCH PARTNERS L P

THREE ARCH ASSOCIATES L P

  • Director
  • 10% Owner
7,950,123 2012-05-29 0

SKYLINE VENTURE PARTNERS QUALIFIED PURCHASER FUND IV L P

SKYLINE VENTURE MANAGEMENT IV, LLC

HOFFMAN STEPHEN J

KANEKO YASUNORI

FREUND JOHN GORDON

  • Director
  • 10% Owner
4,161,933 2012-05-29 0

THREE ARCH MANAGEMENT III LLC

WAN MARK A

JAEGER WILFRED E

THREE ARCH PARTNERS III LP

THREE ARCH ASSOCIATES III LP

  • Director
  • 10% Owner
12,594,709 2011-02-16 0

THREE ARCH MANAGEMENT IV, L.L.C.

THREE ARCH ASSOCIATES IV LP

WAN MARK A

JAEGER WILFRED E

THREE ARCH PARTNERS IV LP

  • Director
  • 10% Owner
12,594,709 2011-02-16 0

ACP IV, L.P.

NOHRA GUY P

JANNEY DANIEL

DELEAGE JEAN

MACK DAVID HENRY

ACMP IV LLC

  • Director
  • 10% Owner
2,794,907 2011-02-16 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ACELRX PHARMACEUTICALS INC ACRX 2021-10-27 22:15:03 UTC -2.7796 2.8496 2400000
ACELRX PHARMACEUTICALS INC ACRX 2021-10-27 21:45:03 UTC -2.7796 2.8496 2400000
ACELRX PHARMACEUTICALS INC ACRX 2021-10-27 21:15:03 UTC -2.7796 2.8496 2400000
ACELRX PHARMACEUTICALS INC ACRX 2021-10-27 20:45:03 UTC -2.7796 2.8496 2400000
ACELRX PHARMACEUTICALS INC ACRX 2021-10-27 20:15:04 UTC -2.7796 2.8496 2400000
ACELRX PHARMACEUTICALS INC ACRX 2021-10-27 19:45:03 UTC -2.7796 2.8496 2400000
ACELRX PHARMACEUTICALS INC ACRX 2021-10-27 19:15:04 UTC -2.7796 2.8496 2400000
ACELRX PHARMACEUTICALS INC ACRX 2021-10-27 18:45:03 UTC -2.7796 2.8496 2400000
ACELRX PHARMACEUTICALS INC ACRX 2021-10-27 18:15:03 UTC -2.7796 2.8496 2400000
ACELRX PHARMACEUTICALS INC ACRX 2021-10-27 17:45:03 UTC -2.7796 2.8496 2400000
ACELRX PHARMACEUTICALS INC ACRX 2021-10-27 17:15:04 UTC -2.7796 2.8496 2400000
ACELRX PHARMACEUTICALS INC ACRX 2021-10-27 16:45:03 UTC -2.7796 2.8496 2400000
ACELRX PHARMACEUTICALS INC ACRX 2021-10-27 16:15:03 UTC -2.7796 2.8496 2400000
ACELRX PHARMACEUTICALS INC ACRX 2021-10-27 15:45:03 UTC -2.9098 2.9798 2400000
ACELRX PHARMACEUTICALS INC ACRX 2021-10-27 15:15:03 UTC -2.9098 2.9798 2100000
ACELRX PHARMACEUTICALS INC ACRX 2021-10-27 14:45:03 UTC -3.0564 3.1264 1800000
ACELRX PHARMACEUTICALS INC ACRX 2021-10-27 14:15:04 UTC -3.0564 3.1264 1800000
ACELRX PHARMACEUTICALS INC ACRX 2021-10-27 13:45:03 UTC -3.0564 3.1264 1800000
ACELRX PHARMACEUTICALS INC ACRX 2021-10-27 13:15:03 UTC -3.0564 3.1264 1700000
ACELRX PHARMACEUTICALS INC ACRX 2021-10-27 12:45:03 UTC -3.0564 3.1264 1700000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund ACRX -13020.0 shares, $-17967.6 2021-06-30 N-PORT
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund ACRX -93966.0 shares, $-110879.88 2021-07-31 N-PORT

Elevate your investments